In tumor cells, COX-2 is often overexpressed, which in turn upregulates PGE2 and contributes to the immune evasion and cancer immunotherapy resistance creating an environment rich in IL-10 and TGF-β, cytokines known to promote regulatory T cells (Tregs) differentiation and proliferation (21–29). This evidence concerns the gene PTGS2 and neoplasm.